Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

por Whitford, P., Mallon, E. A., George, W. D., Campbell, A. M.
Publicado 1990

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

por Tovey, S M, Brown, S, Doughty, J C, Mallon, E A, Cooke, T G, Edwards, J
Publicado 2009

Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival

por Elsberger, B, Tan, B A, Mallon, E A, Brunton, V G, Edwards, J
Publicado 2010

Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997

por Brown, S B F, Mallon, E A, Edwards, J, Campbell, F M, McGlynn, L M, Elsberger, B, Cooke, T G
Publicado 2009

Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression

por Elsberger, B, Fullerton, R, Zino, S, Jordan, F, Mitchell, T J, Brunton, V G, Mallon, E A, Shiels, P G, Edwards, J
Publicado 2010

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

por Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Publicado 2013